Pharmaceuticals, Biotechnology and Life Sciences
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026;…
Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million Robust clinical pipeline with multibillion dollar opportunities and…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in…
LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) — Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled…
– Rapidly transforming into a leading global biopharma companyCOPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq:…
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year FacilityNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited…
Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan.…
Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you…
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…